Affiliation:
1. FSBI “Zakusov Institute of Pharmacology”
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science
Reference14 articles.
1. Lapin I., Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug. CNS Drug Rev. 2001; 7(4):471-481. DOI:10.1111/j.1527-3458.2001.tb00211.x
2. Zavadenko N. N., Yu S.N. Attention deficit disorder: Study of motor control, memory and experience with nootropics, Eur J Paediatr Neurol. 1999;3(6):A86. DOI:10.1016/S1090-3798(99)91216-3
3. Kovalev GI, Sukhorukova NA, Vasileva EV et al. Analysis of behavioral and neuroreceptor effects of atomoxetine and phenibut in CD-1 mice subpopulations diverging in sustained attention. Eksperimental'naia i Klinicheskaia Farmakologiia, 2021; 84(4):3-11. DOI:10.30906/0869-2092-2021-84-4-3-11.
4. Borodkina LE, Kudrin VS, Klodt PM. et al., Effect of phenibut on the content of monoamines, their metabolites, and neurotransmitter amino acids in rat brain structures. Eksperimental'naia i Klinicheskaia Farmakologiia, 2009; 72(1):60-63. DOI:10.30906/0869-2092-2009-72-1-60-63
5. Kovalev GI, Salimov RM, Sukhorukova NA et al. Neuroreceptor Profile and Behavior of CD-1 Mice Subpopulations with Different Attention Stability. Neurochemical Journal. 2020;37(1):1-9. DOI:10.1134/S1819712420010146.